PLENARY SPEAKERS AND TOPICS
Click on the name of the presenter to find which day and time the present, their presentation title and their full bio.
Philip Calder is Professor of Nutritional Immunology within the Human Development and Health Academic Unit of the Faculty of Medicine at the University of Southampton in the UK. He has a PhD in Biochemistry from University of Auckland (New Zealand) and a DPhil in Biochemistry from University of Oxford (UK). He is a Registered Nutritionist and a Fellow of both the Royal Society of Biology and the Association for Nutrition.
Susan Carlson, PhD, received her bachelor's in home economics at Washington State University in 1969 and her doctorate in nutrition (minors in biochemistry and physiology) from Iowa State University in 1975. She had NICHD postdoctoral fellowships at the University of Wisconsin in the Dept. of Pathology (1975-1977) and at the University of South Florida in the Dept. of Pediatrics (1978-1979).
Carlson and Colombo have been active in large clinical trials studying infant DHA supplementation and DHA administered to women entering their second trimester of pregnancy. The goal of these trials is to evaluate the effect of DHA provided pre- and postnatally on visual development and behavior of infants, toddlers and, eventually, preschoolers.
Dr. Jingyuan Fu is an associate professor of Bioinformatics in the University Medical Centre Groningen, the Netherlands. She studied Biochemistry (BSc) in China and then developed her scientific career in the fields of systems genetics and integrative genomics. In the Netherlands she gained an MSc in bioinformatics (with distinction) from Wageningen University in 2003 and a PhD cum laude from University of Groningen in 2007. In 2008, Fu joined the University Medical Centre Groningen as a post-doctoral researcher; she was appointed an associate professor in 2015. She has been awarded various funds for her research, including a VENI grant in 2009 and a VIDI in 2014 from the Netherlands Organization of Scientific Research (NWO).
Dr. Ingelsson obtained his MD (2000) and PhD (2005) at Uppsala University, Sweden. After internship, he did a residency in general medicine (2003-2006) and took up a postdoctoral research fellowship at the Framingham Heart Study (2006-2007). He moved to Karolinska Institutet (Stockholm, Sweden) in 2007 and was appointed Professor of Cardiovascular Epidemiology in 2010. From 2013-2016, he was a Professor of Molecular Epidemiology at Uppsala University. He was also a Visiting Professor at the Wellcome Trust Centre for Human Genetics at University of Oxford in 2012-2015. Since May 2016, he is Professor of Medicine at Stanford University.
Dr. David J. Mangelsdorf received his B.S. in Biology and Chemistry from Northern Arizona University in Flagstaff (1981) and his Ph.D. in Biochemistry from the University of Arizona in Tucson (1987). He did his postdoctoral studies at The Salk Institute for Biological Studies. Since 1993 he has been at UT Southwestern, where he currently is Professor and Chair of the Department of Pharmacology, and an Investigator of the Howard Hughes Medical Institute. He holds the Alfred G. Gilman Distinguished Chair in Pharmacology and the Raymond and Ellen Willie Distinguished Chair in Molecular Neuropharmacology, in Honor of Harold B. Crasilneck, Ph.D. He has been a member of the National Academy of Sciences and The Academy of Medicine, Engineering and Science of Texas since 2008.
Charles is the Simon Gelman Professor of Anaesthesia (Biochemistry and Molecular Pharmacology) at Harvard Medical School, Professor of Oral Medicine, Infection and Immunity at HSDM, and Director of the Center for Experimental Therapeutics and Reperfusion Injury at Brigham and Women’s Hospital. He received a BS in biochemistry from Stony Brook University followed by a doctorate in experimental pathology and medical sciences from New York University School of Medicine. He was a visiting scientist and post-doctoral fellow at the Karolinska Institutet, Stockholm with Professor Bengt Samuelsson 1982 Nobel Laureate. In 1987, he joined the faculty at Harvard Medical School and received an honorary degree from Harvard University (1996).
TOPICS TO BE CONSIDERED
By no means exhaustive, the following is a list of topics expected to be covered during the Congress.